SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8605Increased prolactin recently caused a scare (overblown in my view) with RisperdaBiomaven-7/25/2005
8604rozerem.com Rozerem™ is indicated for the treatment of insomnia characterized bIamarangerboy-7/25/2005
8603I read late August to late September. Apparently the label for R contains potenRobohogs-7/25/2005
8602<i> It will not even be available until late August</i> Today’s WSJDewDiligence_on_SI-7/25/2005
8601<i>saturating receptors cause failure of repolarization</i> Don'Biomaven-7/23/2005
8600may be reading their phase III wrong, but it appears that the 8 mg reached signiIamarangerboy-7/22/2005
8599It will not even be available until late August: yahoo.reuters.comDewDiligence_on_SI-7/22/2005
8598brandweek.com <<< Takeda said it could start marketing of the drug as David Howe-7/22/2005
8597Rozerem approved by FDA (eom)DewDiligence_on_SI-7/22/2005
8596<i>hoping to be able to try something better</i> Just because it doBiomaven-7/22/2005
8595A shame—I was hoping to be able to try something better than Lunesta, which is wDewDiligence_on_SI-7/22/2005
8594OT: I discover today that Harold Engstrom banned me from the Elan thread and putJill-7/22/2005
8593We all know that is because these guys, Takeda and SNY are all keeping their reakenhott-7/22/2005
8592The Ramelteon presentations at the APSS were pretty marginal. Sleep latency in oBiomaven-7/22/2005
8591Jon, total scripts should be a pretty good number, total per slide is 638k (slidkenhott-7/22/2005
8590Ramelteon filed on Sept 24, 2004. So Takeda should have answer from FDA by todakenhott-7/22/2005
8589The Next Ambien? Matthew Herper, 07.21.05, 6:00 AM ET NEW YORK - Is a sleeper hIcebrg-7/22/2005
8588There is something funky with the total starts data at 192,000 cumulative considRobohogs-7/22/2005
8587<i>Piper is assuming sales of L will drop in Q4</i> I think they maBiomaven-7/21/2005
8586Yes - it started at 10% and fell to 3% late in quarter. Also increase Rx size tRobohogs-7/21/2005
8585--<Piper... $79x2 = $158 + 82 = 240 MM minus excess fill of 20 = 220. How youkenhott-7/21/2005
8584<<Why do you think that Sepracor is down after a very strong report?>&gtnsaf-7/20/2005
8583quid, Typically the patient doesn't visit the doctor to get the re-authorizBiomaven-7/20/2005
8582I think it is clear that SEPR didn't expect full approval on the MDI and so Biomaven-7/20/2005
8581Jon, thanks, and that goes to my point: it seems that it's in the patient&#quidditch-7/20/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News